SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings.
Publication/Presentation Date
8-1-2015
Abstract
Neuroblastoma is the most common extracranial solid tumor in childhood in high-income countries (HIC), where consistent treatment approaches based on clinical and tumor biological risk stratification have steadily improved outcomes. However, in low- and middle- income countries (LMIC), suboptimal diagnosis, risk stratification, and treatment may occur due to limited resources and unavailable infrastructure. The clinical practice guidelines outlined in this manuscript are based on current published evidence and expert opinions. Standard risk stratification and treatment explicitly adapted to graduated resource settings can improve outcomes for children with neuroblastoma by reducing preventable toxic death and relapse.
Volume
62
Issue
8
First Page
1305
Last Page
1316
ISSN
1545-5017
Published In/Presented At
Parikh, N. S., Howard, S. C., Chantada, G., Israels, T., Khattab, M., Alcasabas, P., Lam, C. G., Faulkner, L., Park, J. R., London, W. B., Matthay, K. K., & International Society of Pediatric Oncology (2015). SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings. Pediatric blood & cancer, 62(8), 1305–1316. https://doi.org/10.1002/pbc.25501
Disciplines
Medicine and Health Sciences | Pediatrics
PubMedID
25810263
Department(s)
Department of Pediatrics
Document Type
Article